http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017105738-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_539cc92d0db94099de5ebd60ab1a559a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate | 2015-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f50bbeb2f7b33bed4d7319e38b886e4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6db2238ddb598bc0684b6e2046dc2afa |
| publicationDate | 2017-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2017105738-A |
| titleOfInvention | Neimanpick disease type C preventive and / or therapeutic agent |
| abstract | [Problem] To provide a pharmaceutical composition having an action of improving the stability of NPC1 mutant and a decrease in folding efficiency and useful for the prevention and / or treatment of Niemann-Pick disease type C. A preventive and / or therapeutic agent for Niemann-Pick disease type C comprising a compound represented by formula (I), an ester or a salt thereof as an active ingredient. (Ar1 to Ar3 are each independently a substituted / unsubstituted aromatic group; X1 is CH2 or O; preferably Ar3 is a 4-alkyl-1,2,4-triazol-5-one group). |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7365094-B2 |
| priorityDate | 2015-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 366.